SSX2 and synovial sarcoma: SS, which is also considered a stem cell malignancy resulting from dysregulation of self-renewal and multi-lineage differentiation capacities induced by SS18-SSX oncoproteins, displays expression of neural tissue-related genes [1, 44, 53, 125].